4//SEC Filing
MCCLUNG BARBARA G 4
Accession 0001209191-22-050315
CIK 0001619856other
Filed
Sep 15, 8:00 PM ET
Accepted
Sep 16, 4:14 PM ET
Size
10.9 KB
Accession
0001209191-22-050315
Insider Transaction Report
Form 4
MCCLUNG BARBARA G
Chief Legal Officer
Transactions
- Exercise/Conversion
Common Stock
2022-09-15$2.69/sh+77$207→ 349,048 total - Exercise/Conversion
Common Stock
2022-09-15$2.69/sh+27,518$74,023→ 376,566 total - Exercise/Conversion
Option to purchase Common Stock
2022-09-15−27,518→ 47,318 totalExercise: $2.69Exp: 2029-09-30→ Common Stock (27,518 underlying) - Exercise/Conversion
Option to purchase Common Stock
2022-09-15−77→ 0 totalExercise: $2.69Exp: 2028-06-11→ Common Stock (77 underlying)
Footnotes (2)
- [F1]The shares subject to this option vested in equal monthly installments until the option became fully vested on June 12, 2022.
- [F2]The shares subject to this option have vested or will vest in equal monthly installments until the option is fully vested on October 1, 2023, subject to the reporting person's continued service to the Issuer through the applicable vesting dates.
Documents
Issuer
Caribou Biosciences, Inc.
CIK 0001619856
Entity typeother
Related Parties
1- filerCIK 0001231321
Filing Metadata
- Form type
- 4
- Filed
- Sep 15, 8:00 PM ET
- Accepted
- Sep 16, 4:14 PM ET
- Size
- 10.9 KB